US3472859A
(en)
|
1966-11-01 |
1969-10-14 |
Sterling Drug Inc |
1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
|
JPS4826772U
(pt)
|
1971-08-02 |
1973-03-31 |
|
|
EP0062001B1
(de)
|
1981-03-24 |
1987-05-27 |
Ciba-Geigy Ag |
Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
|
US4656283A
(en)
|
1982-05-25 |
1987-04-07 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
|
US4910327A
(en)
|
1982-05-25 |
1990-03-20 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof
|
US4710507A
(en)
|
1983-12-22 |
1987-12-01 |
Pfizer Inc. |
Quinolone inotropic agents
|
FR2634483B2
(fr)
|
1987-12-29 |
1994-03-04 |
Esteve Labor Dr |
Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
|
CA2002864C
(en)
|
1988-11-29 |
1999-11-16 |
Eddy J. E. Freyne |
(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
US5478832A
(en)
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
JPH0826772A
(ja)
|
1994-07-22 |
1996-01-30 |
Sony Corp |
融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
|
EP0709377B1
(en)
|
1994-10-27 |
1999-09-29 |
Asahi Glass Company Ltd. |
Process for producing quinolin-2-yl benzoic acid compounds
|
GB9523267D0
(en)
|
1995-11-14 |
1996-01-17 |
Sandoz Ltd |
Organic compounds
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
JP2000511532A
(ja)
|
1996-05-20 |
2000-09-05 |
メルク エンド カンパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモンのアンタゴニスト
|
RU2209066C2
(ru)
|
1997-06-02 |
2003-07-27 |
Янссен Фармацевтика Н.В. |
Производные (имидазол-5-ил)метил-2-хинолинона в качестве ингибиторов пролиферации клеток гладкой мышцы
|
ATE303993T1
(de)
|
1997-12-22 |
2005-09-15 |
Pharmacia & Upjohn Co Llc |
4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
|
FR2776388B1
(fr)
|
1998-03-20 |
2006-04-28 |
Lipha |
Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
ES2199579T3
(es)
|
1998-07-06 |
2004-02-16 |
Janssen Pharmaceutica N.V. |
Inhibidores de la proteina farnesil-transferasa con propiedades de sensibilizacion in vivo.
|
HU229358B1
(en)
|
1998-07-06 |
2013-11-28 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
JP2000169451A
(ja)
|
1998-09-30 |
2000-06-20 |
Kyorin Pharmaceut Co Ltd |
6,7―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
|
DE69907964T2
(de)
|
1998-12-23 |
2004-02-19 |
Janssen Pharmaceutica N.V. |
1,2-annelierte chinolinderivate
|
US6248736B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
|
US6248739B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
OA11833A
(en)
|
1999-02-11 |
2005-08-23 |
Pfizer Prod Inc |
Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents.
|
ES2212971T3
(es)
|
1999-11-30 |
2004-08-16 |
Pfizer Products Inc. |
Derivados de quinolina utiles para la inhibicion de la farnesil protein transferasa.
|
PT1255537E
(pt)
|
2000-02-04 |
2006-09-29 |
Janssen Pharmaceutica Nv |
Inibidores da proteina farnesil transferase para tratar cancro da mama
|
DE60130976T2
(de)
|
2000-02-24 |
2008-07-17 |
Janssen Pharmaceutica N.V. |
Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs
|
US20030022918A1
(en)
|
2000-02-29 |
2003-01-30 |
Horak Ivan David |
Farnesyl protein transferase inhibitor combinations with an her2 antibody
|
EP1265611A2
(en)
|
2000-02-29 |
2002-12-18 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with taxane compounds
|
EP1261356A2
(en)
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
WO2001064198A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
|
US20030125326A1
(en)
|
2000-02-29 |
2003-07-03 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations
|
AU2001256166A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
|
CA2397253A1
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
|
AU2001235496A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
|
US20030212008A1
(en)
|
2000-02-29 |
2003-11-13 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
|
JP2003525236A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ビンカアルカロイドとのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
EP1261341A2
(en)
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
US6844357B2
(en)
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
US6525049B2
(en)
|
2000-07-05 |
2003-02-25 |
Pharmacia & Upjohn Company |
Pyrroloquinolones as antiviral agents
|
US6624159B2
(en)
|
2000-07-12 |
2003-09-23 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
TR200402534T4
(tr)
|
2000-07-12 |
2004-12-21 |
Pharmacia & Upjohn Company |
Viral enfeksiyonların tedavisinde yararlı oksazinokuinolonlar.
|
AU2002220559A1
(en)
|
2000-09-25 |
2002-04-02 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
|
US7067531B2
(en)
|
2000-09-25 |
2006-06-27 |
Angibaud Patrick Rene |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
|
EP1322635B1
(en)
|
2000-09-25 |
2006-03-22 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
BR0114253A
(pt)
|
2000-10-02 |
2003-07-01 |
Janssen Pharmaceutica Nv |
Antagonistas de receptor de glutamato metabotrópico
|
US20040044032A1
(en)
|
2000-11-28 |
2004-03-04 |
End David William |
Farnesyl protein transfer inhibitors for the treatment of inflammatory bowel disease
|
WO2002051835A1
(en)
|
2000-12-27 |
2002-07-04 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
|
WO2002064142A1
(en)
|
2001-02-15 |
2002-08-22 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with antiestrogen agents
|
EP1363887A1
(en)
|
2001-03-01 |
2003-11-26 |
PHARMACIA & UPJOHN COMPANY |
Substituted quinolinecarboxamides as antiviral agents
|
JP2004526776A
(ja)
|
2001-04-25 |
2004-09-02 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
悪液質を治療するためのファルネシルタンパク質トランスフェラーゼ阻害剤
|
EP1412367A4
(en)
|
2001-06-21 |
2006-05-03 |
Ariad Pharma Inc |
NEW CHINOLINE AND ITS USE
|
AR037940A1
(es)
|
2001-12-20 |
2004-12-22 |
Upjohn Co |
Compuestos antivirales de piridoquinoxalina
|
JP2005516957A
(ja)
|
2001-12-20 |
2005-06-09 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
ピリドキノキサリン抗ウイルス剤
|
EA009334B1
(ru)
|
2002-03-29 |
2007-12-28 |
Янссен Фармацевтика Н.В. |
Меченные радиоактивными изотопами производные хинолина и их применение в качестве лигандов метаботропного глутаматного рецептора
|
EP2045242A1
(en)
|
2002-08-13 |
2009-04-08 |
Shionogi&Co., Ltd. |
Heterocyclic compounds having inhibitory activity against HIV integrase
|
WO2004019932A1
(en)
|
2002-08-30 |
2004-03-11 |
Pharmacia & Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
GB0222516D0
(en)
|
2002-09-27 |
2002-11-06 |
Karobio Ab |
Novel compounds
|
EA010023B1
(ru)
|
2003-07-14 |
2008-06-30 |
Арена Фармасьютикалз, Инк. |
Конденсированные арильные и гетероарильные производные в качестве модуляторов метаболизма и для профилактики и лечения расстройств, связанных с нарушением метаболизма
|
AU2004295058B9
(en)
|
2003-11-20 |
2011-06-30 |
Janssen Pharmaceutica N.V. |
6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
NZ547193A
(en)
|
2003-12-05 |
2010-03-26 |
Janssen Pharmaceutica Nv |
6-Substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
WO2005058843A1
(en)
|
2003-12-10 |
2005-06-30 |
Janssen Pharmaceutica N.V. |
Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
CA2547518A1
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
PT1711181E
(pt)
|
2004-01-23 |
2009-12-29 |
Janssen Pharmaceutica Nv |
Derivados quinolina e sua utilização como inibidores micobacterianos
|
AU2005210036B2
(en)
|
2004-01-29 |
2010-12-23 |
Janssen Pharmaceutica N.V. |
Quinoline derivatives for use as mycobacterial inhibitors
|
JP4969443B2
(ja)
|
2004-06-30 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Parp阻害剤としてのキナゾリノン誘導体
|
EP1780202B1
(en)
|
2004-08-04 |
2013-02-27 |
Meiji Seika Pharma Co., Ltd. |
Quinoline derivative and insecticide containing same as active constituent
|
KR100686531B1
(ko)
|
2004-08-31 |
2007-02-23 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
|
PL2362218T3
(pl)
|
2004-11-05 |
2015-02-27 |
Janssen Pharmaceutica Nv |
Sposoby kontroli skuteczności inhibitorów transferazy farnezylowej
|
JO2952B1
(en)
|
2005-08-03 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
JO2855B1
(en)
|
2005-08-03 |
2015-03-15 |
شركة جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
JP5112083B2
(ja)
|
2006-02-03 |
2013-01-09 |
Meiji Seikaファルマ株式会社 |
新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
KR101083177B1
(ko)
|
2006-10-23 |
2011-11-11 |
에스지엑스 파마슈티컬스, 인코포레이티드 |
트리아졸로-피리다진 단백질 키나제 조정제
|
JO3271B1
(ar)
|
2006-12-06 |
2018-09-16 |
Janssen Pharmaceutica Nv |
مشتقات الكوينولين المضادة للجراثيم
|
AR065093A1
(es)
|
2007-02-05 |
2009-05-13 |
Merck Frosst Canada Ltd |
Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
US20100184803A1
(en)
|
2007-03-09 |
2010-07-22 |
Link Medicine Corporation |
Treatment of Lysosomal Storage Diseases
|
EA200971077A1
(ru)
|
2007-05-21 |
2010-04-30 |
ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК. |
Гетероциклические модуляторы киназы
|
CN101143845B
(zh)
|
2007-10-15 |
2010-08-25 |
中国药科大学 |
取代喹啉甲酰胍衍生物、其制备方法及其医药用途
|
BRPI0906927A2
(pt)
|
2008-01-18 |
2015-07-21 |
Allergan Inc |
Compostos de substituída-aril-(imidazol)-metil)-fenila como moduladores seletivos de subtipo de receptores alfa 2b e/ou alfa 2c adrenérgicos
|
CA2714232A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
EP2296655A1
(en)
|
2008-05-13 |
2011-03-23 |
Allergan, Inc. |
Quinolynylmethylimidizoles as therapeutic agents
|
WO2010068296A1
(en)
|
2008-12-11 |
2010-06-17 |
Stiefel Laboratories, Inc. |
Piperazine carboxamidines as antimicrobial agents
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
CN101899011B
(zh)
|
2009-05-26 |
2013-01-16 |
北京大学 |
氨基二硫代甲酸酯类化合物、其制备方法和应用
|
TWI428332B
(zh)
|
2009-06-09 |
2014-03-01 |
Hoffmann La Roche |
雜環抗病毒化合物
|
AR077267A1
(es)
|
2009-06-25 |
2011-08-17 |
Amgen Inc |
Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
|
IN2012DN01453A
(pt)
|
2009-08-20 |
2015-06-05 |
Novartis Ag |
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
US9101600B2
(en)
|
2010-03-11 |
2015-08-11 |
New York University |
Compounds as RORγt modulators and uses thereof
|
MX2012011996A
(es)
|
2010-04-15 |
2013-11-27 |
Chromocell Corp |
Compuestos , composiciones y metodos para reducir o eliminar el sabor amargo.
|
US9512111B2
(en)
|
2010-11-08 |
2016-12-06 |
Lycera Corporation |
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
EP2487159A1
(en)
*
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
US11179500B2
(en)
|
2011-02-24 |
2021-11-23 |
Emory University |
JAB1 inhibitory compositions for ossification and methods related thereto
|
JP5902029B2
(ja)
|
2011-04-28 |
2016-04-13 |
日本たばこ産業株式会社 |
アミド化合物およびその医薬用途
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
US20140315881A1
(en)
*
|
2011-07-29 |
2014-10-23 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
EP2738170B1
(en)
*
|
2011-07-29 |
2017-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
GB201118652D0
(en)
*
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
JP5918859B2
(ja)
|
2011-12-02 |
2016-05-18 |
フェネックス ファーマシューティカルス アーゲー |
オーファン核内受容体RARに関連するオーファン受容体−ガンマ(RORγ、NR1F3)活性の調整剤としての、慢性の炎症性疾患および自己免疫性疾患を治療するためのピロロカルボキサミド
|
MX358508B
(es)
|
2012-10-16 |
2018-08-22 |
Janssen Pharmaceutica Nv |
Moduladores de quinolinilo unidos a metileno de receptor nuclear de acido retinoico-gamma-t.
|
ES2628365T3
(es)
*
|
2012-10-16 |
2017-08-02 |
Janssen Pharmaceutica N.V. |
Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
|
US9303015B2
(en)
*
|
2012-10-16 |
2016-04-05 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORγt
|
US9221804B2
(en)
*
|
2013-10-15 |
2015-12-29 |
Janssen Pharmaceutica Nv |
Secondary alcohol quinolinyl modulators of RORγt
|
CA2927182A1
(en)
*
|
2013-10-15 |
2015-04-23 |
Janssen Pharmaceutica Nv |
Quinolinyl modulators of ror.gamma.t
|
US9284308B2
(en)
*
|
2013-10-15 |
2016-03-15 |
Janssen Pharmaceutica Nv |
Methylene linked quinolinyl modulators of RORγt
|
US9403816B2
(en)
*
|
2013-10-15 |
2016-08-02 |
Janssen Pharmaceutica Nv |
Phenyl linked quinolinyl modulators of RORγt
|
US9328095B2
(en)
*
|
2013-10-15 |
2016-05-03 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORgammat
|